PMC:7546139 / 15487-15767
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T86 | 30-31 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T87 | 73-81 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
| T88 | 206-212 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | active |
| T89 | 260-268 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T75 | 35-38 | Chemical | denotes | NaF | http://purl.obolibrary.org/obo/CHEBI_28741 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T158 | 0-280 | Sentence | denotes | Treatment with 38% SDF and/or a 5% NaF varnish therapy to reduce carious activity and promote remineralisation.33 These additional measures can support success of the NRCC approach if the carious lesion is active or there is increased risk that carious lesion activity will recur. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 138 | 35-38 | Gene | denotes | NaF | Gene:3576 |
| 139 | 19-22 | Chemical | denotes | SDF | MESH:C024633 |
| 140 | 188-202 | Disease | denotes | carious lesion | MESH:D003731 |
| 141 | 245-259 | Disease | denotes | carious lesion | MESH:D003731 |